Polynucleotides (PDRN) in Phototherapy / LED Treatment Protocols
Polynucleotides (PDRN) plays a key role in professional phototherapy / led treatment treatments. DNA fragments derived from salmon or trout sperm that activate salvage pathway purine metabolism, stimulating fibroblast proliferation and tissue regeneration.
Role of Polynucleotides (PDRN) in Phototherapy / LED Treatment
Exposure to specific wavelengths of light (red 630nm, blue 415nm, near-infrared 830nm) to stimulate cellular processes, reduce bacteria, and promote healing Polynucleotides (PDRN) enhances this treatment through its bio-revitalisation properties, providing regenerative support during and after the procedure.
Protocol Integration
In a typical phototherapy / led treatment protocol, polynucleotides (pdrn) can be utilised at several stages:
- Pre-treatment: Skin preparation with polynucleotides (pdrn)-containing products to optimise treatment outcomes
- During treatment: Active polynucleotides (pdrn) delivery through the treatment modality for enhanced penetration
- Post-treatment: Recovery support using polynucleotides (pdrn) formulations to accelerate healing
Clinical Benefits
Combining polynucleotides (pdrn) with phototherapy / led treatment offers several advantages:
- Enhanced bio-revitalisation through professional delivery methods
- Improved treatment outcomes with medical-grade regenerative support
- Reduced downtime and faster recovery when supported by polynucleotides (pdrn)
Skymedic Products
Skymedic offers professional-grade polynucleotides (pdrn) formulations specifically designed for integration with phototherapy / led treatment protocols. All products manufactured under ISO 13485 standards.